B2M and metastatic melanoma: In one case report, investigators tracked the chronological sequence of appearance of B2M gene mutation in several successive metastatic melanoma lesions and a lymph node biopsy-derived cell line obtained after immunotherapy with a dendritic cell vaccine (DCV) transfected with autologous tumor mRNA (30).